Gene and Cell Therapy – Multimedia
eBook
Cell and Gene Therapies: From the Lab to the Clinic
Cell and gene therapies are at the forefront of innovation in modern medicine, changing how we study and treat human disease. Download this eBook to explore advances, applications and approaches to cell and gene therapies.
Listicle
Economies of Scale: The Top 5 Considerations for Successful Cell and Gene Therapy Fill/Finish Scale-Up
How can you successfully scale your cell and gene therapy fill/finish process to minimize manual involvement, reduce the specialized training required, and deliver high-quality, high-value products, efficiently?
eBook
Ensuring Biotherapeutic Products Are Mycoplasma-Free
Vaccines, cell and gene therapy products must be certified as mycoplasma-free to meet regulatory requirements. Hence, mycoplasma contamination testing is a vital step in the biologics manufacturing process.
How To Guide
A Guide to Gene and Cell Therapy Workflows
This handbook offers a practical guide to end-to-end GCT workflows, featuring tips, tricks and solutions to support a variety of high-throughput applications.
Video
Revolutionizing Drug Discovery With Genomic Screening
This episode explores revolutionizing drug discovery with genomic screening.
Video
"Environmental Monitoring in Biopharmaceutical Facilities
In this episode we discuss environmental monitoring, regulations, and introduce the Applied Biosystems MicroSEQ™ Rapid microbial ID system.
How To Guide
Exploring Successful Cell and Gene Therapy Development
Cell and gene therapies and regenerative medicines (CGT&RMs) offer remarkable biotherapeutic promise. However, developing and manufacturing CGT&RMs is no easy task, particularly when choosing how and where to deliver the production of a therapeutic.
eBook
An Introduction to Organ-on-a-Chip Technology
This eBook provides an introduction to Organ-on-a-Chip technology and highlights the latest solutions available to support drug discovery.
How To Guide
Five Tips on Navigating Your Biotherapeutic Journey
It is expected that within four to five years, biologics will comprise over half of the 100 top selling drugs on the market. However, the high cost and complexity of biotherapeutic development, as well as a dynamic regulatory landscape, still poses challenges to drug developers.
Listicle
Cancer Immunotherapies: Transforming Treatment for Patients
Download this listicle to learn more about immune checkpoint inhibitors and immune system modulators, adoptive cell therapies and oncolytic viral therapy.
Advertisement